RELMADA THERAPEUTICS, INC. - RLMD
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 12
Latest filed: Jun 22, 2026
| Form | Count |
|---|---|
| SCHEDULE 13G | 6 |
| 8-K | 4 |
| SCHEDULE 13G/A | 2 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Jun 22, 2026 | SCHEDULE 13G | — | 0001104659-26-076490 | View |
| Jun 09, 2026 | SCHEDULE 13G | — | 0001738048-26-000066 | View |
| May 28, 2026 | 8-K | May 27, 2026 | 0001213900-26-062184 | View |
| May 13, 2026 | SCHEDULE 13G/A | — | 0000919574-26-002929 | View |
| May 12, 2026 | 8-K | May 12, 2026 | 0001213900-26-055164 | View |
| May 04, 2026 | SCHEDULE 13G | — | 0001831942-26-000017 | View |
| Mar 20, 2026 | 8-K | Mar 19, 2026 | 0001213900-26-032403 | View |
| Mar 09, 2026 | 8-K | Mar 09, 2026 | 0001213900-26-024918 | View |
| Feb 17, 2026 | SCHEDULE 13G | — | 0000902664-26-001027 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0002050709-26-000007 | View |
| Feb 12, 2026 | SCHEDULE 13G | — | 0000902664-26-000914 | View |
| Feb 06, 2026 | SCHEDULE 13G | — | 0001274173-26-000046 | View |